• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 2.84% Nasdaq Down 2.94%

    More On ESALY

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials

    • Income Statement
    • Balance Sheet
    • Cash Flow

    Eisai Co., Ltd. (ESALY)

    -Other OTC
    63.21 Down 4.76(7.00%) 3:59PM EDT
    Add to Portfolio
    Prev Close:67.97
    Open:63.14
    Bid:N/A
    Ask:N/A
    1y Target Est:97.39
    Beta:-1.0446
    Next Earnings Date:N/A
    Day's Range:62.96 - 63.21
    52wk Range:35.79 - 80.41
    Volume:1,316
    Avg Vol (3m):2,506
    Market Cap:18.06B
    P/E (ttm):50.45
    EPS (ttm):1.25
    Div & Yield:1.34 (1.96%)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ESALY

    Key Statistics

    Forward P/E (1 yr):65.84
    P/S (ttm):4.20
    Ex-Dividend Date:26-Mar-15

    Analysts

    Annual EPS Est (Mar-16) :0.74
    Quarterly EPS Est (0-00-31) :N/A
    Mean Recommendation*:1.0
    PEG Ratio (5 yr expected):16.84

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Eisai Co., Ltd. manufactures and sells pharmaceutical products worldwide. The company offers oncology-related products, such as Halaven, an anticancer agent; Aloxi, an antiemetic agent; and Fragmin, an injectable anticlotting agent, as well as Sym... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback